← FDA DRUG APPROVALS

FDA ANDA · ANDA201573

FENOFIBRIC ACID

Sponsor: PH HEALTH

APPLICATION
ANDA201573
TYPE
ANDA
ORIGINAL APPROVAL
2013-07-18
LATEST ACTION
2020-10-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED RELEASE
MARKETING STATUS
Discontinued

Products

FENOFIBRIC ACIDDiscontinued
CHOLINE FENOFIBRATE EQ 135MG FENOFIBRIC ACID · CAPSULE, DELAYED RELEASE · ORAL
FENOFIBRIC ACIDDiscontinued
CHOLINE FENOFIBRATE EQ 45MG FENOFIBRIC ACID · CAPSULE, DELAYED RELEASE · ORAL

Approval history

2020-10-29Labeling · Supplement 10 · standardAP
2015-07-06Labeling · Supplement 6 · standardAP
2013-07-18UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →